Skip to main content

NCI s Core Genotyping Facility to Use Inforsense KDE for Genetic Data Analysis

NEW YORK, Aug. 30 (GenomeWeb News) - The National Cancer Institute's core genotyping facility has selected InforSense's KDE as its high-throughput genetics data-analysis platform, the company said today.


Under the five-year agreement, scientists at the core facility in Gaithersburg, Md., will use InforSense KDE to develop applications for their own research and to publish analysis methods via a web portal.


"After an extensive review of the available commercial and open source options, we recognized that InforSense KDE is able to provide the functionality, flexibility, and scalability we need to support our research, and to develop caBIG (Cancer Biomedical Informatics Grid) compatible applications," said Meredith Yeager, scientific director of the genotyping facility, in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.